| LINE ITEM (USD / %) | FY 2025
FILED 2026-01-31 | FY 2024
FILED 2025-01-25 | FY 2023
FILED 2024-01-27 |
|---|---|---|---|
| Revenue (Total Sales) | $5.55B | $4.70B | $4.18B |
| YoY Revenue Growth % | +17.9% | +12.6% | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $331.6M | $277.3M | $258.4M |
| Operating Margin % | 6.0% | 5.9% | 6.2% |
| Net Income (GAAP) | $281.0M | $235.0M | $219.0M |
| EBITDA (Normalized) | $524.2M | $477.7M | $408.7M |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $642.5M | $349.1M | $259.0M |
| Capital Expenditures (CapEx) | $240.8M | $250.5M | $187.9M |
| Free Cash Flow (FCF) | $401.7M | $98.6M | $71.1M |
| FCF Margin % | 7.2% | 2.1% | 1.7% |
| Return on Invested Capital (ROIC %) | 6.6% | 10.5% | 6.7% |
| Cash & Short-Term Equivalents | $709.2M | $92.7M | — |
| Total Debt (Short + Long Term) | $2.81B | $933.2M | $1.17B |
| Total Stockholders' Equity | $1.86B | $1.24B | $2.41B |